PALISADE Follow-on Study (ARC004)
Clinical trial NCT02993107 · COMPLETED
Trial details
- NCT number
- NCT02993107
- Sponsor
- Aimmune Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-29
- Primary completion
- 2019-05-31
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.